Skip to main content
Guerbet logo

Guerbet — Investor Relations & Filings

Ticker · GBT ISIN · FR0000032526 LEI · 969500WV1U1WQ059L135 PA Manufacturing
Open in API
Filings indexed 623 across all filing types
Latest filing 2019-12-18 Board/Management Inform…
Country FR France
Listing PA GBT

About Guerbet

https://www.guerbet.com

Guerbet is a global specialist in medical imaging, offering a comprehensive range of solutions and services for diagnostic and interventional procedures. The company develops and manufactures contrast media, medical devices such as injectors, and related software for X-ray, Magnetic Resonance Imaging (MRI), and Interventional Imaging. With a history of innovation dating back to 1926, Guerbet focuses on providing healthcare professionals with tools to enhance diagnostic accuracy and improve patient care. Its portfolio is designed to support a wide array of clinical applications, from initial diagnosis to treatment monitoring.

Recent filings

Filing Released Lang Actions
Guerbet: David Hale appointed CEO of Guerbet as from January 1, 2020 to accelerate deployment of the Group’s strategy
Board/Management Information Classification · 99% confidence The document is a press release dated December 18th, 2019, announcing a significant change in senior management: the appointment of David Hale as the new CEO, effective January 1, 2020, replacing Yves L'Epine. This content directly aligns with the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management.
2019-12-18 English
GUERBET : Déclaration des opérations sur actions propres du 09 au 13 décembre 2019 (agrégée)
Transaction in Own Shares Classification · 99% confidence The document explicitly states its purpose: 'Le présent document a pour finalité de présenter les opérations réalisées dans le cadre du programme de rachat d'actions autorisé par l'Assemblée Générale Ordinaire du 24 mai 2019 sur la période du 09 au 13 décembre 2019.' It then provides detailed tables showing the volume and price of shares repurchased daily. This content directly corresponds to the definition of a report detailing the company buying back or selling its own shares, which is classified as 'Transaction in Own Shares' (POS). The document length (4204 chars) is substantial enough to be the report itself, not just an announcement of a report.
2019-12-16 French
Déclaration des opérations sur actions propres du 09 au 13 décembre 2019 (détaillée)
Director's Dealing Classification · 95% confidence The document text consists of a detailed table showing transactions ('Opérations réalisées') involving the issuer 'GUERBET' during a specific period (December 9th to 13th, 2019). The table includes columns for 'Nom de l'émetteur' (Issuer Name), 'Prix unitaire' (Unit Price), 'Quantité achetée' (Quantity bought), and 'Objectif du rachat' (Purpose of the repurchase), which is listed as 'STOCK' or 'OPTIONS'. This structure is characteristic of mandatory regulatory filings reporting insider transactions or significant share dealings by directors/executives. Based on the definitions, this directly corresponds to 'Director's Dealing' (DIRS) or potentially 'Transaction in Own Shares' (POS). Since the data details specific transactions by an entity (likely an insider or related party, given the context of such detailed reporting), and the purpose mentions 'STOCK'/'OPTIONS' transactions, 'DIRS' (Director's Dealing) is the most appropriate fit for reporting personal share transactions by executives/directors, which often includes options exercises/deals. If the transactions were solely the company buying back its own stock, POS would fit, but the structure strongly suggests mandatory disclosure of individual transactions, aligning best with DIRS.
2019-12-16 English
GUERBET : Déclaration des opérations sur actions propres (agrégée) - Du 02 au 06 décembre 2019
Transaction in Own Shares Classification · 99% confidence The document explicitly states its purpose: 'Le présent document a pour finalité de présenter les opérations réalisées dans le cadre du programme de rachat d'actions autorisé par l'Assemblée Générale Ordinaire du 24 mai 2019 sur la période du 02 au 06 décembre 2019.' This clearly indicates a report detailing transactions involving the company buying back its own shares (share repurchase). This aligns directly with the definition for 'Transaction in Own Shares' (Code: POS). Although it mentions the AGM authorization, the content is the execution report, not the AGM material itself.
2019-12-09 French
Déclaration des opérations sur actions propres (détaillée) - Du 02 au 06 décembre 2019
Director's Dealing Classification · 95% confidence The document text consists of detailed tables showing transactions ('Opérations réalisées') involving the issuer 'GUERBET' and a 'PSI' (presumably a reporting entity or intermediary) over several days in December 2019. The table columns include transaction date/time, price, currency, quantity, and 'Objectif du rachat' (Purpose of repurchase), which is listed as 'STOCK OPTIONS'. This structure strongly indicates a report detailing personal share transactions by executives or directors, or transactions related to share schemes, which aligns with the definition of Director's Dealing (DIRS) or potentially Transaction in Own Shares (POS) if the transactions were buybacks. However, since the transactions are detailed reports of specific trades by an entity ('CREDIT INDUSTRIEL ET COMMERCIAL' acting on behalf of GUERBET, likely related to employee stock options/plans), the most fitting category is Director's Dealing (DIRS), which covers insider trades and transactions by executives/directors, often including stock option exercises/sales. Given the detailed, transactional nature, it is not a general announcement (RPA/RNS) but the report itself.
2019-12-09 English
GUERBET : Enregistrement de Vectorio® en Inde, un dispositif médical innovant pour les procédures cTACE
Regulatory Filings Classification · 95% confidence The document is explicitly titled "Communiqué de presse" (Press Release) multiple times. It announces a specific corporate event: the registration approval of a medical device (Vectorio®) in India. This type of announcement, detailing a business development or product milestone, is typically classified as an Earnings Release (ER) if it contains key financial highlights, or more generally as a Regulatory Filing (RNS) if it's a general corporate update that doesn't fit other specific categories like M&A (TAR) or Capital Change (CAP). Since this is a specific product/market approval announcement, and it is not a full financial report (like 10-K or IR), nor a transcript (CT), nor a management discussion (MDA), the most appropriate general category for a press release announcing a significant business event is often the Earnings Release category if it's periodic, or RNS if it's ad-hoc. Given the content is a business update/announcement rather than a formal financial results release, RNS (Regulatory Filings/General Announcement) is a strong candidate, but ER is often used for press releases announcing significant operational news, even if not strictly quarterly earnings. However, looking at the definitions, this is a specific business development announcement. Since there is no specific category for 'Product Launch/Approval Press Release', and it is not a formal financial report, it falls best under the general Regulatory Filings (RNS) or potentially ER if the database treats all press releases as ERs. Given the nature of the announcement (product registration approval), RNS is the safest fallback for a non-standard corporate announcement. I will classify it as RNS as it is a general regulatory/business announcement press release.
2019-12-03 French

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.